中国生物制药拟8月18日举行董事会会议批准中期业绩

格隆汇资讯
01 Aug

格隆汇8月1日丨中国生物制药(01177.HK)宣布,公司将于2025年8月18日(星期一)举行董事会会议,藉以批准(其中包括)刊发公司及其附属公司截至2025年6月30日止六个月期间的未经审核中期业绩,以及考虑派发中期股息(如有)。

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10